Tarsons Products Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tarsons Products Limited - overview
Established
1983
Location
Kolkata, West Bengal, India
Primary Industry
Medical Devices & Equipment
About
Based in Kolkata, India, and founded in 1983, Tarsons Products Limited, f. k. a Tarsons Products Private Limited, is a manufacturer and supplier of laboratory plasticware products, intended for biological and medical purposes. In August 2018, ADV Partners invested in the company, and in November 2021, Tarsons Products Limited made an IPO of INR 1,023.
47 crores, by listing its equity shares on National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). As of 2021, the company is being led by Sanjive Sehgal, as its Chairperson and Managing Director, and the firm operates 5 manufacturing facilities in West Bengal and supplies its products to more than 40 countries internationally. Tarsons Products Limited manufactures, distributes, and sells laboratory plasticware products that are used in various pharmaceutical companies, hospitals, academic institutes, research centers, diagnostic centers, etc. The product portfolio can be categorized into consumables, reusables, and others, and this includes bottles, carboys, centrifuge ware, cryo labware, measuring cylinders, test tube racks, pipette tips, Petri dishes, desiccators, incubation trays, mini coolers, vortex shakers, liquid handling system, and instruments, and many more.
The firm manufactures over 1,700 SKUs (stock-keeping units) across 300 products. Tarsons Products Limited generated INR 234. 2 crores in the financial year 2021. The company plans to use the proceeds from the IPO to repay all or part of the firm's debts and develop a new manufacturing facility in West Bengal.
Current Investors
ADV Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Rubber & Plastics
Website
www.tarsons.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Tarsons Products Limited - timeline of key events
Tarsons Products Limited - financials
| Fiscal Year Ended | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,487,200,000 | 1,885,932,196 | 1,749,848,899 | 2,289,110,000 | - | - | - |
| % Revenue Growth (YoY) | - | 26.8% | (7.2%) | 30.8% | - | - | - |
| EBITDA (USD) | 530,700,000 | 785,357,534 | 706,085,968 | 1,085,260,000 | - | - | - |
| Operating Income (USD) | 398,600,000 | 639,719,716 | 564,921,748 | 948,640,000 | - | - | - |
| Operating Margin | 26.8% | 33.9% | 32.3% | 41.4% | - | - | - |
| % EBITDA Margin | 35.7% | 41.6% | 40.4% | 47.4% | - | - | - |
| NET Income (USD) | 189,200,000 | 398,710,387 | 384,611,897 | 688,700,000 | - | - | - |
| % Net Margin | 12.7% | 21.1% | 22.0% | 30.1% | - | - | - |
Tarsons Products Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Nerbe R&D Gmbh | - | ||||||||
| Add-on | Completed | Nerbe Plus Gmbh & Co. KG | - | ||||||||
| IPO | Completed | Tarsons Products Limited | - | ||||||||
| Growth | Completed | Tarsons Products Limited | - |
Displaying 1 - 4 of 4
Tarsons Products Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.